Open Nav

Histogen, Inc.

  • Gail Naughton, Histogen

Fundraising and partnering

  • Date:Wednesday, October 17
  • Time:4:00 PM - 4:15 PM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Histogen is a regenerative medicine company focused on stimulating the body’s stem cells to regenerate tissues and restore youthful function. Its technology is based upon delivering the growth factors and cell-signaling proteins which are naturally secreted by hypoxia-induced multipotent stem cells. The Company’s lead therapeutic product for hair growth has shown success in early clinical trials, addressing a multi-billion dollar market opportunity. Histogen has recently closed a skin care partnership with Allergan for the dermatology market, and is actively seeking a retail skin care partner. Additional applications of Histogen’s technology span multiple therapeutic and aesthetic areas, including wound healing and orthopedics.
  • Company
  • Company HQ City:San Diego
  • Company HQ Country:United States
  • Company HQ State:California                  
  • Main Therapeutic Focus:Dermatology
  • Lead Product in Development :HSC660 for hair growth
  • Development Phase of Primary Product:Phase II
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :3
  • Previous and Current Investors:Huapont Life Sciences, Lordship Ventures, Secure Medical
  • Total Amount Raised to Date, In All Rounds:$38M
Gail Naughton